false
OasisLMS
Catalog
SCCM Resource Library
More Than Just Choosing the Aspirin Dose: Stroke C ...
More Than Just Choosing the Aspirin Dose: Stroke Care in the ICU
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, Thalia Froke, a NeuroICU Clinical Pharmacist Specialist, discusses updates on the management of acute ischemic stroke. She talks about the use of tenecteplase as a thrombolytic agent and its efficacy in acute ischemic stroke. She highlights the differences between tenecteplase and alteplase, including the fibrin-specificity and longer half-life of tenecteplase. Froke also discusses the use of dual antiplatelet therapy (DAPT) in acute ischemic stroke and mentions conflicting results on its effectiveness. She provides an overview of the agents used in DAPT, including aspirin. Froke further discusses the use of IV antiplatelets, such as Kangrelor and Eptafibatide, in neuroendovascular procedures. She compares the two agents and their onset of action, dosing, and clearance. Froke presents several studies that evaluated the use of Kangrelor and Eptafibatide in acute ischemic stroke and their outcomes. She also provides sample protocols for the use of these agents. In conclusion, Froke emphasizes the effectiveness of tenecteplase, the controversial role of DAPT, and the value of IV antiplatelet agents in high-risk patients undergoing endovascular procedures.
Asset Subtitle
Neuroscience, 2023
Asset Caption
Type: two-hour concurrent | Time Is Brain: An Update on Management and Pharmacology Strategies for Acute Neurologic Emergencies (SessionID 1202433)
Meta Tag
Content Type
Presentation
Knowledge Area
Neuroscience
Membership Level
Professional
Membership Level
Select
Tag
Stroke
Year
2023
Keywords
acute ischemic stroke
tenecteplase
alteplase
dual antiplatelet therapy
IV antiplatelets
×
Please select your language
1
English